Piasecki to lead Torre Lazur U.S. as Breitenbach exits

Share this article:
Torre Lazur McCann has appointed Marci Piasecki chief executive for its U.S. operations following the resignation of Beverley Breitenbach. Piasecki, who previously headed East Hanover, N.J.-based Echo Torre Lazur, reports to Richard Nordstrom, chairman and chief executive of Torre Lazur McCann Worldwide. She heads Torre Lazur McCann U.S. offices in Parsippany and East Hanover, N.J., San Diego and Chicago.
Piasecki worked for Torre Lazur McCann from 1992-2001, handling GlaxoSmithKline oncology and vaccine accounts, before joining Hyphen, where she headed client services. She re-joined Torre Lazur McCann in November, 2004.
Torre Lazur McCann said Breitenbach had resigned her post and "separately will announce future plans." Breitenbach could not be reached for this story.
Share this article:

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.